Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Robert A. Wirtz

Phase 2a Trial of 0, 1, and 3 Month and 0, 7, and 28 Day Immunization Schedules of Malaria Vaccine RTS,S/AS02 in Malaria-Naïve Adults at the Walter Reed Army Institute of Research

Vaccine

English

Serologic and Genetic Characterization of Plasmodium Vivax From Whole Blood-Impregnated Filter Paper Discs

American Journal of Tropical Medicine and Hygiene

English

Related publications

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

New England Journal of Medicine

Medicine

2008

English

Assessment of Severe Malaria in a Multicenter, Phase III, RTS, S/As01 Malaria Candidate Vaccine Trial: Case Definition, Standardization of Data Collection and Patient Care

English

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area

PLoS ONE

Multidisciplinary

2009

English

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

BMC Medicine

Medicine

2014

English

Statistical Methodology for the Evaluation of Vaccine Efficacy in a Phase III Multi-Centre Trial of the RTS,S/AS01 Malaria Vaccine in African Children

English

The RTS,S/AS01 Malaria Vaccine in Children 5 to 17 Months of Age at First Vaccination

Expert Review of Vaccines

English

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Human Vaccines

2011

English

Efficacy and Safety of RTS,S/AS01 Malaria Vaccine With or Without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial

The Lancet

Medicine

2015

English

Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Robert A. Wirtz

Phase 2a Trial of 0, 1, and 3 Month and 0, 7, and 28 Day Immunization Schedules of Malaria Vaccine RTS,S/AS02 in Malaria-Naïve Adults at the Walter Reed Army Institute of Research

Serologic and Genetic Characterization of Plasmodium Vivax From Whole Blood-Impregnated Filter Paper Discs

Related publications

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

Assessment of Severe Malaria in a Multicenter, Phase III, RTS, S/As01 Malaria Candidate Vaccine Trial: Case Definition, Standardization of Data Collection and Patient Care

Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area

A Combined Analysis of Immunogenicity, Antibody Kinetics and Vaccine Efficacy From Phase 2 Trials of the RTS,S Malaria Vaccine

Statistical Methodology for the Evaluation of Vaccine Efficacy in a Phase III Multi-Centre Trial of the RTS,S/AS01 Malaria Vaccine in African Children

The RTS,S/AS01 Malaria Vaccine in Children 5 to 17 Months of Age at First Vaccination

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Efficacy and Safety of RTS,S/AS01 Malaria Vaccine With or Without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial

Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania